User:Cleanthis/draft nicot

Cleanthis/draft nicot

File:Nicotin-3D-vdW.png
Clinical data
Dependence liability	Medium to high
Routes of administration	smoked (as smoking tobacco, mapacho, etc.), insufflated (as tobacco snuff or nicotine nasal spray), chewed (as nicotine gum, tobacco gum or chewing tobacco), transdermal (as nicotine patch, nicogel or topical tobacco paste), intrabuccal (as dipping tobacco, snuffs, dissolvable tobacco or creamy snuff), vaporized (as electronic cigarette, etc.), directly inhaled (as nicotine inhaler), oral (as nicotini)
ATC code	N07BA01 (WHO) QP53AX13 (WHO)
Legal status
Legal status	AU: Unscheduled UK: Unscheduled US: Unscheduled, but age restricted.
Pharmacokinetic data
Bioavailability	20 to 45% (oral)
Metabolism	hepatic
Elimination half-life	2 hours
Identifiers
IUPAC name 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
CAS Number	54-11-5
PubChem CID	942
DrugBank	DB00184
ChemSpider	80863
Chemical and physical data
Formula	C10H14N2
Molar mass	162.26 g/mol g·mol−1
3D model (JSmol)	Interactive image
Density	1.01 g/cm3
Melting point	−79 °C (−110 °F)
Boiling point	247 °C (477 °F)
SMILES C1=CC=NC=C1[C@@H]2CCCN2C
(verify)